Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: The role of nitric oxide

被引:61
作者
Chen, Hui [1 ]
Xing, Bianzhi [2 ]
Liu, Xiuheng [1 ]
Zhan, Bingyan [1 ]
Zhou, Jiangqiao [1 ]
Zhu, Hengcheng [1 ]
Chen, Zhiyuan [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Peoples R China
[2] HUST, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan, Peoples R China
关键词
ozone oxidative preconditioning; ischemia/reperfusion; NO; eNOS; iNOS; ET-1;
D O I
10.1016/j.jss.2007.12.756
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Ischemia/reperfusion (I/R) injury, which is commonly seen in the field of renal surgery or transplantation, is a major cause of acute renal failure. Previous studies have shown that ozone oxidative preconditioning (OzoneOP) attenuated renal I/R injury. The objective of this study was to examine the hypothesis that protective effects of OzoneOP in renal I/R injury were associated with endogenous NO. Materials and methods. In a right-nephrectomized rat mode, anesthetized rats underwent 45 min of renal ischemia. OzoneOP (1 mg/kg) was administered before I/R injury. Rats were killed at 24,48, and 72 h after I/R injury and blood samples and renal tissues were obtained. Results. OzoneOP prevented the renal dysfunction induced by I/R and increased nitric oxide (NO) release and renal NO synthase (endothelial, eNOS, and inducible, iNOS) expression. In contrast, enhancement of endothelin-1 in the kidney after the reperfusion was markedly suppressed by OzoneOP. Conclusions. Our findings indicated that the protective effect of OzoneOP was closely related to the NO production following the increase in eNOS and iNOS expression. Ozone treatment may have important clinical implications, particularly in view of the minimizing renal damage before transplantation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 52 条
[11]  
FIRTH JD, 1988, LANCET, V2, P1179
[12]   ORGAN DISTRIBUTION OF THE 3 RAT ENDOTHELIN MESSENGER-RNAS AND THE EFFECTS OF ISCHEMIA ON RENAL GENE-EXPRESSION [J].
FIRTH, JD ;
RATCLIFFE, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :1023-1031
[13]   Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis [J].
Furusu, A ;
Miyazaki, M ;
Abe, K ;
Tsukasaki, S ;
Shioshita, K ;
Sasaki, O ;
Miyazaki, K ;
Ozono, Y ;
Koji, T ;
Harada, T ;
Sakai, H ;
Kohno, S .
KIDNEY INTERNATIONAL, 1998, 53 (06) :1760-1768
[14]  
GAUHIER TW, 1994, AM J PHYSIOL, V267, P562
[15]  
GELLAI M, 1995, J PHARMACOL EXP THER, V275, P200
[16]   NO bioavailability, endothelial dysfunction, and acute renal failure: New insights into pathophysiology [J].
Goligorsky, MS ;
Brodsky, SV ;
Noiri, E .
SEMINARS IN NEPHROLOGY, 2004, 24 (04) :316-323
[17]   Nitric oxide in acute renal failure: NOS versus NOS [J].
Goligorsky, MS ;
Brodsky, SV ;
Noiri, E .
KIDNEY INTERNATIONAL, 2002, 61 (03) :855-861
[18]  
Goligorsky MS, 1999, SEMIN NEPHROL, V19, P263
[19]   Long-term cold ischemia reduces nitric oxide metabolism in reperfused rabbit kidneys [J].
Hansen, TN ;
D'Alessandro, A ;
Southard, JH .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) :3417-3419
[20]   DECREASE OF BLOOD CHOLESTEROL AND STIMULATION OF ANTIOXIDATIVE RESPONSE IN CARDIOPATHY PATIENTS TREATED WITH ENDOVENOUS OZONE THERAPY [J].
HERNANDEZ, F ;
MENENDEZ, S ;
WONG, R .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (01) :115-119